Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison to BCG in Healthy Volunteers in South Africa

NCT01113281 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Tuberculosis

Interventions

BIOLOGICAL: VPM1002 live vaccine
BIOLOGICAL: commercially available live vaccine BCG

Sponsor

Serum Life Science Europe GmbH

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]